Lotus Bio-Technology Development Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LBTD research report →
About the company
Lotus Bio-Technology Development Corp. (LBTD) operates as a biotechnology firm, primarily dedicated to the processing of organic substances and the creation of natural consumer products for the Chinese market. This entity, which began its operations in 2011, was formerly recognized as Starflick.
- CEO
- Hoyt Christopher
- IPO
- 2014
- HQ
- Cave Creek, AZ, US
Price Chart
- Market Cap
- $8.06M
- P/E
- -50.00
- P/S
- 0.00
- P/B
- -13.50
- EV/EBITDA
- -412.75
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 31.89%
- ROIC
- 28.35%
- Revenue
- $0 · 0.00%
- Net Income
- $-19,550 · 97.50%
- EPS
- $-0.00 · 97.87%
- Op Income
- $-19,550
- FCF YoY
- -18.46%
- 52W High
- $0.01
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 1.91
- Avg Volume
- 7.24K
Get TickerSpark's AI analysis on LBTD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LBTD coverage
Recent articles, reports, and earnings notes.
No research on LBTD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LBTD report →Similar companies
Peers in the same neighborhood.